Evidence map›Paper›PMID 34500644›Full record

ReviewMolecules (Basel, Switzerland)2021

Chemical Modification of Glycosaminoglycan Polysaccharides.

Lais C G F Palhares, James A London, Aleksandra M Kozlowski, Emiliano Esposito, Suely F Chavante, Minghong Ni, Edwin A Yates

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Polysaccharides and carbohydrate polymers: innovations from nature to industry.Journal of the science of food and agriculture · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Lais C G F PalharesPrograma de Pós-graduação em Bioquímica e Biologia Molecular, Departamento de Bioquímica, Universidade do Rio Grande do Norte (UFRN), Natal 59012-570, Brazil.ORCID 0000-0002-5558-1522
James A LondonDepartment of Biochemistry and Systems Biology, ISMIB, University of Liverpool, Crown Street, Liverpool L69 7ZB, UK.ORCID 0000-0002-5823-7057
Aleksandra M KozlowskiDepartment of Chemistry and Chemical Engineering, Forest Products and Chemical Engineering, Chalmers University of Technology, Kemigården 4, 412 58 Göteborg, Sweden.ORCID 0000-0002-3053-9854
Emiliano EspositoInstituto di Richerche Chemiche e Biochemiche, 'G.Ronzoni', Via G Colombo 81, 20133 Milano, Italy.
Suely F ChavantePrograma de Pós-graduação em Bioquímica e Biologia Molecular, Departamento de Bioquímica, Universidade do Rio Grande do Norte (UFRN), Natal 59012-570, Brazil.
Minghong NiInstituto di Richerche Chemiche e Biochemiche, 'G.Ronzoni', Via G Colombo 81, 20133 Milano, Italy.
Edwin A YatesDepartment of Biochemistry and Systems Biology, ISMIB, University of Liverpool, Crown Street, Liverpool L69 7ZB, UK.ORCID 0000-0001-9365-5433
Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni · ITUniversidade Federal do Rio Grande do Norte · BRUniversity of Liverpool · GBChalmers University of Technology · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The linear anionic class of polysaccharides, glycosaminoglycans (GAGs), are critical throughout the animal kingdom for developmental processes and the maintenance of healthy tissues. They are also of interest as a means of influencing biochemical processes. One member of the GAG family, heparin, is exploited globally as a major anticoagulant pharmaceutical and there is a growing interest in the potential of other GAGs for diverse applications ranging from skin care to the treatment of neurodegenerative conditions, and from the treatment and prevention of microbial infection to biotechnology. To realize the potential of GAGs, however, it is necessary to develop effective tools that are able to exploit the chemical manipulations to which GAGs are susceptible. Here, the current knowledge concerning the chemical modification of GAGs, one of the principal approaches for the study of the structure-function relationships in these molecules, is reviewed. Some additional methods that were applied successfully to the analysis and/or processing of other carbohydrates, but which could be suitable in GAG chemistry, are also discussed.

Indexed as

AnimalsAnticoagulantsGlycosaminoglycansHeparinHumansPolysaccharidesStructure-Activity RelationshipAnticoagulantsGlycosaminoglycansHeparinPolysaccharideschemical modificationglycosaminoglycanspolysaccharidessulfation

Identifiers

PMID34500644
PMCPMC8434129
OpenAlexW3198103025

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.